3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Neuritis: new trials by email Literature Review of Neuritis trials Research Report on Neuritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Lacosamide in Peripheral Neuropathic Pain Lacosamide, Placebo - Neuropathic Pain, Neuropathy;Peripheral | Phase 2 | Terminated | Danish Pain Research Center | 63 | 2019-01-15 | 2023-02-16 |
| Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis CNM-Au8, Placebo - Relapsing Remitting Multiple Sclerosis, Optic Neuropathy | Phase 2 | Terminated | Clene Nanomedicine | 73 | 2018-11-23 | 2023-04-03 |
| Atacicept in Subjects With Optic Neuritis Atacicept, Placebo matched to atacicept - Optic Neuritis | Phase 2 | Terminated | EMD Serono | 34 | 2008-06-01 | 2016-02-17 |
Demyelinating Diseases (1) · Diabetic Neuropathies (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Neuralgia (1) · Neuropathy, Painful (1) · Optic Nerve Diseases (1) · Optic Neuritis (1)
Nervous System Diseases (3) · Neuromuscular Diseases (3) · Peripheral Nervous System Diseases (3) · Cranial Nerve Diseases (2) · Eye Diseases (2) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Demyelinating Autoimmune Diseases, CNS (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Immune System Diseases (1) · Multiple Sclerosis (1) · Neurologic Manifestations (1) · Optic Nerve Diseases (1)
Lacosamide (1) · TACI receptor-IgG Fc fragment fusion protein (1)
Clene Nanomedicine (1) · Danish Pain Research Center (1) · EMD Serono (1)
Australia (2) · Canada (2) · United States (2) · Belgium (1) · Czechia (1) · Denmark (1) · France (1) · Germany (1) · Lebanon (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Heidi Beadnall, MD (1) · Nanna B Finnerup, Professor (1)
2018 (1)